8-K - Karyopharm Therapeutics Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Karyopharm Therapeutics Inc. held a Special Meeting of Stockholders on February 18, 2026. The 8-K filing reports this event under Item 5.07, Submission of Matters to a Vote of Security Holders.

Key Takeaways

1Special Meeting of Stockholders held on February 18, 2026

2Reported under Item 5.07

3Filing dated February 19, 2026

Current Report Details

Event Type

Shareholder Vote

Disclosure

Mandatory

Variant

8-K

Items Reported

5.07

. Submission of Matters to a Vote of Security Holders. On February 18, 2026, Karyopharm Therapeutics Inc. (the “Company”) held a Special Meeting of Stockholders

Shareholder Vote

Exhibits (1)

8-K